This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Vaginal Inserts Market

Market Insights on Vaginal Inserts covering sales outlook, demand forecast & up-to-date key trends

Vaginal Inserts Market By Product Type (Vaginal Tablets, Vaginal Capsules, Vaginal Suppositories), Applications (Vaginal Inserts for Birth Control, Vaginal inserts for Feminine Hygiene, Vaginal inserts for Fungal Infections), Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy, Fertilization Centers) & Region - Forecast 2022-2032

Vaginal Inserts Market Overview

Global Vaginal Inserts demand is projected to be valued at US$ 1.65 Billion in 2022, forecast to grow at a CAGR of 5.2% to be valued at US$ 2.7 Billion from 2022 to 2032. Growth is attributed to the rising demand for renovation projects and development in residential and commercial construction.

Report Attribute

Details

Estimated Base Year Value (2021)

US$ 1.58 Billion

Expected Market Value (2022)

US$ 1.65 Billion

Anticipated Forecast Value (2032)

US$ 2.7 Billion

Projected Growth Rate (2022-2032)

5.2% CAGR

Vaginal Inserts are solid dosage drug form that is inserted into the vagina with the help of a special applicator. Vaginal inserts have advantages over other dosage forms as it will increase the local concentration of the drug and are also beneficial in refractory cases. Drugs taken in the form of vaginal inserts melt inside the body and absorb directly into the bloodstream.

Vaginal inserts can be used for several indications. Such as birth control, fungal infections, vaginal dryness, hormone supplementation, and vitamin supplementation.

Which are Some Prominent Drivers Spearheading Vaginal Inserts Market Growth?

The global vaginal Inserts market has witnessed growth due to the increasing use of vaginal inserts in birth control, fungal infections, vaginal dryness, hormone supplementation, and vitamin supplementation. With growing awareness about birth control, the use of contraceptive vaginal contraceptives is gaining popularity over conventional contraceptive pills due to its fewer side effects and also a major reason for the growth of the vaginal inserts market.

In the U.S. vaginal candidiasis is the second most common type vaginal infection next to bacterial vaginal infections. Clotrimazole vaginal inserts, Monistat 3 vaginal inserts, and Terconazole vaginal inserts are the first line of treatment for vaginal candidiasis. The incidence of vaginal candidiasis is rising globally. The rising incidence of vaginal candidiasis which required to use vaginal inserts for treatment is a vital factor that positively influences the growth of the market.

Moreover, the rising use of vaginal inserts for estrogen supplements, menstrual pain relief, and the treatment of vaginal dryness also fuelling the vaginal inserts market.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Challenges Faced by the Vaginal Inserts Industry?

Although few factors such as mucosal irritation, patient compliance, and erratic and undesired absorption can restrain the concerned market.

Why is Asia-Pacific Emerging as an Opportunistic Vaginal Inserts Market?

Asia-Pacific accounted for the highest market share in 2020. The rise in the number of women populations in countries like India and China along with the rising inclination of females towards maintaining personal hygiene has driven the sales of feminine hygiene products ultimately contributing to the growth of the overall market. This awareness about vaginal hygiene has created a plethora of growth opportunities for vaginal inserts in the region.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

How is Europe Contributing to the Growth of the Vaginal Inserts Market?

Owing to the increased disposal of income and enhanced efforts by the government agencies towards increasing the awareness of intimate hygiene & the upward trend toward female hygiene products, the demand for vaginal inserts has increased in the European region.

As per the WHO’s report, the European Medicines Agency (EMA) has given approval to the dapivirine ring for HIV prevention for women in high HIV burden settings. An EMA positive opinion paves the way for regulatory approvals for the ring in countries where women could benefit from additional HIV prevention options. 

Why does North America Hold a Significant Share in the Vaginal Inserts Market?

North America’s Vaginal Inserts market is expanding because of the high adoption rate and it will remain dominant over the period of forecast due to the rising incidence of vaginal candidiasis and raising awareness for feminine hygiene.

As per market research, Feminine Hygiene products sales have increased tremendously in recent years, despite continued price pressure and fierce competition. Development in the organized retail market, technical advancements, and swelling demand for organic products has been the other factors driving the growth of the feminine hygiene products market.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Market Competition

Some of the key participants present in the global demand for Vaginal Inserts market include Meyer Organics Pvt Ltd, Rapross Pharmaceuticals Pvt Ltd, Endocare India, Skymax Laboratories Pvt Ltd, Indica Laboratories Pvt Ltd, Sanzyme Ltd, Hetero Drugs Ltd, Glenmark Pharmaceuticals Ltd, Sun Pharmaceutical Industries Ltd, and Aristo Pharmaceuticals Pvt Ltd.

  • Meyer Organics Pvt Ltd has recently developed Candifem vaginal tablet containing ornidazole and miconazole. It is effective against vaginal infections caused by Candida species, Torulopsis species, Trichomonas vaginalis, and certain gram-positive and gram-negative microorganisms.

Report Scope

Report Attribute

Details

Growth Rate

CAGR of 5.2% from 2022 to 2032

Base Year for Estimation

2021

Historical Data

2016-2021

Forecast Period

2022-2032

Quantitative Units

Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis

Segments Covered

  • Product Type
  • Application
  • Distribution Channel
  • Region

Regions Covered

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific excluding China & Japan
  • China
  • Japan
  • Middle East and Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Argentina
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • Nordics
  • BENELUX
  • Australia & New Zealand
  • China
  • India
  • ASEAN
  • GCC
  • South Africa

Key Companies Profiled

  • Meyer Organics Pvt. Ltd
  • Rapross Pharmaceuticals Pvt. Ltd
  • Endocare India
  • Skymax Laboratories Pvt. Ltd
  • Indica Laboratories Pvt. Ltd
  • Sanzyme Ltd
  • Hetero Drugs Ltd
  • Glenmark Pharmaceuticals Ltd
  • Sun Pharmaceutical Industries Ltd
  • Aristo Pharmaceuticals Pvt. Ltd.

Key Segments Profiled in the Vaginal Inserts Industry Survey

By Product Type:

  • Vaginal Tablets
  • Vaginal Capsules
  • Vaginal Suppositories

By Applications:

  • Vaginal Inserts for Birth Control
  • Vaginal Inserts for Feminine Hygiene
  • Vaginal Inserts for Fungal Infections
  • Vaginal Inserts for Other Applications

By Distribution Channel:

  • Vaginal Inserts Sales through Retail Pharmacy
  • Vaginal Inserts Sales through Hospital Pharmacy
  • Vaginal Inserts Sales through Online Pharmacy
  • Vaginal Inserts Sales through Fertilization Centers

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific excluding China & Japan
  • China
  • Japan
  • Middle East and Africa

Frequently Asked Questions

FMI projects the global demand of the vaginal inserts market to expand at a 5.2% value CAGR by 2032

North America is expected to be the most opportunistic vaginal inserts market

Meyer Organics Pvt Ltd, Rapross Pharmaceuticals Pvt. Ltd, Endocare India, Skymax Laboratories Pvt. Ltd and Indica Laboratories Pvt. Ltd are some prominent vaginal inserts manufacturers

Table of Content

NA

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

NA

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

NA

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Vaginal Inserts Market